companies / openevidence-com

OpenEvidence

Stock summary

Generated 2026-11-09 UTC · publication cutoff 2026-11-09

Insufficient cited evidence for a two-sentence summary.

Investors and explicit leads

OpenEvidence was listed in Greycroft's portfolio, recorded 2026-09-29.
Evidence · 1 citation
- Greycroft · retrieved 2026-09-29
OpenEvidence was listed in Meritech's portfolio, recorded 2026-09-30.
Evidence · 1 citation
- Meritech · retrieved 2026-09-30

verified=2026-06-08 json

total_raised	410,000,000410.0M	○
founded	2021
hq	Cambridge, US
industry	unknown
stage	series-b+

OpenEvidence is an AI medical search engine that answers clinical questions with evidence-based summaries citing peer-reviewed literature, plus DeepConsult agents and Coding Intelligence. It serves practicing physicians: 650K US doctors and 1.2M international. OpenEvidence was the first AI to score a perfect 100% on the USMLE.

acquisitions n=0

No cited completed company acquisition recorded.

traction n=0

Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.

No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.

valuations n=0

No cited valuation with an explicit basis is recorded.

revenue multiples n=0

Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.

No qualifying pair recorded.

rounds n=1

date	type	amount	lead	src
2025-10-20	series-c	200,000,000200.0M	null	○

2025-10-20 series-c200,000,000200.0M

null ○

people n=0

No person is documented for this company.

investors n=3

investor	src
Sequoia Capital	○
Greycroft	○
Meritech	○

Sequoia Capital ○

investor

Greycroft ○

investor

Meritech ○

investor

stack

@sentry/browser, hsts, jquery, material ui, next.js, paper.js, react, sentry, vercel, webpack

provenance

fact	status	src
Series C, $200.0M	attributed	○
Investor Greycroft	sourced	WEB
Investor Meritech	sourced	WEB
existence	self-reported	WEB
description	self-reported	WEB

Series C, $200.0M○

attributed

Investor GreycroftWEB

sourced

Investor MeritechWEB

sourced

existenceWEB

self-reported

descriptionWEB

self-reported

change_history

date	fact	change	src
2026-09-30provenance_investor_meritech: unknown → sourced, WEB 2026-09-30	provenance_investor_meritech	unknown → sourced	WEB 2026-09-30
2026-09-29provenance_investor_greycroft: unknown → sourced, WEB 2026-09-29	provenance_investor_greycroft	unknown → sourced	WEB 2026-09-29
2026-09-27latest_round: series-c, $200.0M, 2025-10-20, lead: sequoia → series-c, $200.0M, 2025-10-20, lead: null, ○ 2026-06-08	latest_round	series-c, $200.0M, 2025-10-20, lead: sequoia → series-c, $200.0M, 2025-10-20, lead: null	○